Effects of lipopolysaccharide and chlorpromazine on glucocorticoid receptor-mediated gene transcription and immunoreactivity: A possible involvement of p38-MAP kinase

European Neuropsychopharmacology

Volumn 14, Issue 6, 2004, Pages 521-528

  Basta Kaim, Agnieszka ^a   Budziszewska, Bogusława ^a   Jaworska Feil, Lucylla ^a   Tetich, Magdalena ^a   Kubera, Marta ^a   Zajicova, Alena ^b   Holan, Vladimir ^b   Lasoń, Władysław ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

Author keywords

Chlorpromazine; Fibroblast cells; GR mediated gene transcription; Lipopolysaccharide

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CHLORPROMAZINE; CORTICOSTERONE; GLUCOCORTICOID RECEPTOR; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNOREACTIVITY; INCUBATION TIME; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL;

CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CHLORAMPHENICOL O-ACETYLTRANSFERASE; CHLORPROMAZINE; DOPAMINE ANTAGONISTS; ENZYME INHIBITORS; FIBROBLASTS; GENE EXPRESSION; HUMANS; IMIDAZOLES; IMMUNITY; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RECEPTORS, GLUCOCORTICOID; SPLEEN; TRANSCRIPTION, GENETIC;

EID: 10344221005     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2004.02.005     Document Type: Article

References (29)

1. Altamura A.C., Boin F., Maes M. HPA axis and cytokines dysregulation in schizophrenia: potential implications for the antipsychotic treatment. Eur. Neuropsychopharmacol. 10:1999;1-4
2. Arango C., Kirkpatrick B., Koenig J. At issue: stress, hippocampal neuronal turnover, and neuropsychiatric disorders. Schizophr. Bull. 27:2001;477-480
3. Bantel H., Schmitz M.L., Raible A., Gregor M., Schulze-Osthoff K. Critical role of nuclear factor-kB and stress-activated protein kinases in steroid unresponsiveness. FASEB J. 16:2002;1832-1834
4. Basta-Kaim A., Budziszewska B., Tetich M., Kubera M., Leśkiewicz M., Jaworska-Feil L., Lasoń W. Effects of lipopolysaccharide on chlorpromazine-induced inhibition of glucocorticoid receptor function in fibroblast cells. Pol. J. Pharmacol. 53:2001;171
5. Basta-Kaim A., Budziszewska B., Jaworska-Feil L., Tetich M., Leśkiewicz M., Kubera M., Lasoń W. Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium dependent manner. Neuropharmacology. 43:2002;1035-1043
6. Basta-Kaim A., Kubera M., Budziszewska B., Jaworska-Feil L., Tetich M., Leśkiewicz M., Korzeniak B., Holan V., Lasoń W. Effects of some psychotropic drugs on immunoendocrine parameters. Pol. J. Pharmacol. 54:2002;184
7. Basta-Kaim A., Kubera M., Budziszewska B., Siwanowicz J., Lasoń W. Effect of some antipsychotic drugs on immunoreactivity in C57BL/6 mice. Pol. J. Pharmacol. 54:2002;737-742
8. Beaudry G., Langlois M.C., Weppe I., Rouillard C., Lévesque D. Contrasting patterns and cellular specificity of transcriptional regulation of the nuclear receptor nerve growth factor-inducible B by haloperidol and clozapine in the rat forebrain. J. Neurochem. 75:2000;1694-1702
9. Budziszewska B., Jaworska-Feil L., Kajta M., Lasoń W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism. Brit. J. Pharmacol. 130:2000;1385-1393
10. Clerk A., Sugden P.H. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett. 426:1998;93-96
11. Goujon E., Laye S., Parnet P., Dantzer R. Regulation of cytokine gene expression in the central nervous system by glucocorticoids: mechanisms and functional consequences. Psychoneuroendocrinology. 22:1997;75-80
12. Irusen E., Matthews J.G., Takahashi A., Barnes P.J., Chung K.F., Adcock I.M. p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109:2002;649-657
13. Kontkanen O., Lakso M., Wong G., Castren E. Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology. 27:2002;152-162
14. Kowalski J., Blada P., Kucia K., Madej A., Herman Z.S. Neuroleptics normalize increased release of interleukin-1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophr. Res. 50:2001;169-175
15. Lammers C.H., Garcia-Borreguero D., Schmider J., Gotthard U., Dettling M., Holsboer F., Heuser I.J.E. Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II. Biol. Psychiatry. 38:1995;803-807
16. Lieberman J., Chakos M., Wu H., Alvir J., Hoffman E., Robinson D., Bilder R. Longitudinal study of brain morphology in first episode schizophrenia. Biol. Psychiatry. 49:2001;487-499
17. Lowry O.H., Rosenbrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chemistry. 193:1951;265-275
18. Miller A.H., Pariante C.M., Pearce B.D. Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv. Exp. Med. Biol. 461:1999;107-116
19. Naudin J., Mege J.L., Azorin J.M., Dassa D. Elevated circulating levels of IL-6 in schizophrenia. Schizophr. Res. 20:1996;269-273
20. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., Miller A.H. Steroid independent translocation of the glucocorticoid receptor by the antidepressant desipramine. Mol. Pharmacol. 52:1997;571-581
21. Pariante C.M., Pearce B.D., Pisell T.L., Sanchez C.I., Po C., Su C., Miller A.H. The proinflammatory cytokine, interleukin-1alpha, reduces glucocorticoid receptor translocation and function. Endocrinology. 140:1999;4359-4366
22. Piazza P.V., Barrot M., Rouge-Pont F., Marinelli M., Maccari S., Abrous D.N., Simon H., Le Moal M. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc. Natl. Acad. Sci. U. S. A. 93:1996;15445-15450
23. Reddi K., Nair S.P., White P.A., Hodges S., Tabona P., Meghji S., Poole S., Wilson M., Henderson B. Surface-associated material from the bacterium Actinobacillus actinomycetemcomitans contains a peptide which, in contrast to lipopolysaccharide, directly stimulates fibroblast interleukin-6 gene transcription. Eur. J. Biochem. 236:1996;871-876
24. Rogatsky I., Logan S.K., Garabedian M.J. Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2050-2055
25. Sadouk M.B., Pelletier J.P., Tardif G., Kiaska K., Cloutier J.M., Martel-Pelletier J. Human synovial fibroblasts coexpress IL-1 receptor type I and type II mRNA. The increased level of the IL-1 receptor in osteoarthritic cells is related to an increased level of the type I receptor. Lab. Invest. 73:1995;347-355
26. Whitmarsh A.J., Yang S.H., Su M.S., Sharrocks A.D., Davis R.J. Role of p38 and JNK mitogen-activated protein kinases in the activation of ternary complex factors. Mol. Cell. Biol. 17:1997;2360-2371
27. Wiegers G.J., Reul J.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol. Sci. 19:1998;317-321
28. Wik G., Wiesel F.A., Eneroth P., Sedvall G., Astrom G. Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatment. Acta Psychiatr. Scand. 74:1986;161-167
29. Xing Z., Jordana M., Braciak T., Ohtoshi T., Gauldie J. Lipopolysaccharide induces expression of granulocyte/macrophage colony-stimulating factor, interleukin-8, and interleukin-6 in human nasal, but not lung, fibroblasts: evidence for heterogeneity within the respiratory tract. Am. J. Respir. Cell Mol. Biol. 9:1993;255-263